CT vendors have diverged this year as never before, choosing technological paths to new generations of scanners that reflect their own particular engineering strengths and history of R&D. Core developments by each have translated into novel capabilities. Software and mechanical fixes have countered weaknesses.
CT vendors have diverged this year as never before, choosing technological paths to new generations of scanners that reflect their own particular engineering strengths and history of R&D. Core developments by each have translated into novel capabilities. Software and mechanical fixes have countered weaknesses.
This collection of articles produced by the vendors provides a glimpse of how their products will be addressed on the RSNA exhibit floor, as well as insights to how each compares with the others.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.